Latest News

The partnership directly supports Dubai’s D33 Economic Agenda and aims to establish the emirate as a global leader in HealthTech innovation.

The Intracept™ Procedure targets the basivertebral nerve, which carries pain signals from damaged vertebral endplates.

The warning comes after an official report from Roche Nigeria, which traced the fake products bearing batch number N2110A09 in Kaduna and Gombe States.

The IMARA–BC initiative targets women aged 40 and above, encouraging them to undergo routine screening so that cancer is detected at stage one or two, when treatment is most effective.

The 460,000-square-foot factory will sit on a 79-acre plot within the Rowen innovation district, near Dacula, Georgia, approximately 35 miles northeast of downtown Atlanta.

This building will accommodate up to 250 researchers and provides a collaborative workspace with modular laboratories designed to support both growth and interdisciplinary exchange.

Construction is expected to be complete by the third quarter of 2027, at which point the site’s workforce is also set to double.

The trial, developed by US-based biopharmaceutical company Opus Genetics, marks a significant step forward in the Emirate’s growing ambition to become a global hub for life sciences and biomedical innovation.

The national rollout of Universal Health Insurance now reaches more communities, while digital transformation accelerates with GoTHOMIS installation reaching 97.8% across public facilities.

Wegovy HD became the fourth drug to receive FDA approval through the Commissioner’s National Priority Voucher pilot programme.